Karyopharm Therapeutics Inc. Operating Leases, Future Minimum Payments, Due in Three Years
Karyopharm Therapeutics Inc. (KPTI) had Operating Leases, Future Minimum Payments, Due in Three Years of $3.28 million as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-02-28
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $3.28M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.39M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.44M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.42M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $3.28M 10-K · filed 2019-02-28 |
| 2017-12-31 | $1.39M 10-K · filed 2018-03-15 |
| 2016-12-31 | $1.44M 10-K · filed 2017-03-16 |
| 2015-12-31 | $1.42M 10-K · filed 2016-03-15 |
| 2014-12-31 | $1.41M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |